Hard work paying off despite challenges from U.S. weather-related events: Fresenius Medical Care CEO
Helen Giza, the CEO of Fresenius Medical Care, discusses the German healthcare firm's third-quarter earnings.
Should Value Investors Buy Fresenius Medical Care AG & Co. (FMS) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the lat...
Here's Why Fresenius (FMS) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
FMS Stock Rides on Diversified Portfolio and Restructuring Initiatives
Fresenius Medical Care's diversified portfolio helps to fight competition and maintain market leadership.
Reasons to Retain Fresenius Medical Stock in Your Portfolio Now
FMS continues to gain traction on the back of its broad dialysis product and service portfolio. Ongoing macro challenges raise concerns.
Fresenius Medical Care Stock Rises on NxStage VersiHD Launch
FMS introduces NxStage VersiHD with GuideMe Software to simplify home dialysis and grow its patient base in the United States.
Fresenius Medical Care CEO says strategy is working as company delivers on transformation efforts
Fresenius Medical Care CEO Helen Giza comments on the firm's second-quarter earning results.
Fresenius Medical (FMS) Q2 Earnings In Line, Operating Margin Up
Fresenius Medical's (FMS) second-quarter revenues suffer due to divestures. However, the company?
Why Fresenius (FMS) is a Top Value Stock for the Long-Term
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Fresenius Medical Care takes next important step towards goal to reduce CO2 emissions in its operations
Fresenius Medical Care enters virtual power purchase agreements for renewable energy to clearly step forward in reducing CO2 emissions footprint Company enacts five virtual power purchase agreement...
Fresenius Medical sees up to 2% US dialysis growth by year-end
The number of kidney dialysis sessions provided by Fresenius Medical Care in its top market, the United States, could rise by as much as 2% by the end of the year, its CEO said, as the impact of th...
Fresenius Medical (FMS) Q1 Earnings Beat, Operating Margin Up
Fresenius Medical's (FMS) first-quarter revenues suffer due to unfavorable currency movement. However, the company's transformational plans continue to benefit its operating income.
Fresenius Medical beats earnings expectations, keeps outlook; shares sink
Fresenius Medical Care beat first-quarter operating earnings expectations on Tuesday amid higher pricing and cost-cut savings, but the German company still maintained its profit outlook for 2024, s...
Fresenius Medical (FMS) to Unveil Training on Augmented Reality
Fresenius Medical (FMS) is launching digital learning elements with hands-on training for Kidney Replacement Therapy leveraging Augmented Reality.
Fresenius Medical (FMS) Q4 Earnings Beat, Operating Margin Up
Fresenius Medical's (FMS) fourth-quarter revenues suffer due to unfavorable currency movement. However, the company?
Related Companies